{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":35848,"items":[{"indexed":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T04:26:01Z","timestamp":1729139161052,"version":"3.27.0"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.euroneuro.2024.08.311","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:38:56Z","timestamp":1729093136000},"page":"155-156","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["T1. BURDEN OF TRAUMA AND PTSD IN EAST AFRICA: RESULTS FROM THE PTSD FOLLOW UP OF THE NEUROGAP-PSYCHOSIS CASE CONTROL STUDY"],"prefix":"10.1016","volume":"87","author":[{"given":"Manasi","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Gichuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaili","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kyebuzibwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karestan","family":"Koenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayden","family":"Mountcastle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linnet","family":"Ongeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocky","family":"Stroud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dickens","family":"Akena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukoye","family":"Atwoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24005108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24005108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:39:50Z","timestamp":1729096790000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24005108"}},"issued":{"date-parts":[[2024,10]]},"references-count":0,"alternative-id":["S0924977X24005108"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.08.311","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T1. BURDEN OF TRAUMA AND PTSD IN EAST AFRICA: RESULTS FROM THE PTSD FOLLOW UP OF THE NEUROGAP-PSYCHOSIS CASE CONTROL STUDY","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.08.311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T04:25:54Z","timestamp":1729139154777,"version":"3.27.0"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.euroneuro.2024.08.364","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T15:40:44Z","timestamp":1729093244000},"page":"184-185","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["T54. INVESTIGATING TRANSCRIPTOMIC PROFILE AND NEURITE OUTGROWTH IN ADHD USING INDUCED PLURIPOTENT STEM CELLS DIFFERENTIATED INTO DOPAMINE NEURONS"],"prefix":"10.1016","volume":"87","author":[{"given":"Atefeh","family":"Namipashaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane D.","family":"Hellyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurina","family":"Arnatkeviciute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron J.","family":"Nowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen J.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Polo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Bellgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziarih","family":"Hawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24005637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X24005637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:41:02Z","timestamp":1729096862000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X24005637"}},"issued":{"date-parts":[[2024,10]]},"references-count":0,"alternative-id":["S0924977X24005637"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.08.364","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T54. INVESTIGATING TRANSCRIPTOMIC PROFILE AND NEURITE OUTGROWTH IN ADHD USING INDUCED PLURIPOTENT STEM CELLS DIFFERENTIATED INTO DOPAMINE NEURONS","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2024.08.364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:52:17Z","timestamp":1720313537495},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s0924-977x(17)30116-5","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T16:30:53Z","timestamp":1488213053000},"page":"S45-S46","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Cross-talk between GABAergic and dopaminergic system: role of GABAA alpha 6 subunit and D3 receptor in ethanol addiction in mice"],"prefix":"10.1016","volume":"27","author":[{"given":"R.","family":"Di Marco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.M.","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Torrisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Giurdanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fidilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Caraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bucolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Drago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17301165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17301165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T01:26:32Z","timestamp":1536024392000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X17301165"}},"issued":{"date-parts":[[2017,3]]},"references-count":0,"alternative-id":["S0924977X17301165"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(17)30116-5","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2017,3]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:52:53Z","timestamp":1720313573824},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s0924-977x(17)31447-5","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T12:32:33Z","timestamp":1510749153000},"page":"S797-S798","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S4","title":["Effects of vortioxetine on composite scores across objective cognitive tests: results from 2 clinical studies in adults with major depressive disorder"],"prefix":"10.1016","volume":"27","author":[{"given":"H.","family":"Loft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.K.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17314475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17314475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T21:51:50Z","timestamp":1535233910000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X17314475"}},"issued":{"date-parts":[[2017,10]]},"references-count":0,"alternative-id":["S0924977X17314475"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(17)31447-5","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:20:29Z","timestamp":1649100029326},"reference-count":2,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1016\/0924-977x(94)90107-4","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T04:03:24Z","timestamp":1039838604000},"page":"297","source":"Crossref","is-referenced-by-count":0,"title":["A new method to describe the impact of two antidepressant treatments in daily life"],"prefix":"10.1016","volume":"4","author":[{"given":"D.Q.C.M.","family":"Barge-Schaapveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.A.","family":"Nicolson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0924-977X(94)90107-4_BIB1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1037\/0022-006X.60.2.225","article-title":"Evaluating the effects of drugs on behavior and Quality of Life: an alternative strategy for clinical trials","volume":"60","author":"Bagne","year":"1992","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/0924-977X(94)90107-4_BIB2","series-title":"The Experience of Psychopathology: Investigating Mental Disorders in their Natural Settings","author":"De Vries","year":"1992"}],"container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0924977X94901074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0924977X94901074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T10:21:01Z","timestamp":1554114061000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0924977X94901074"}},"issued":{"date-parts":[[1994,9]]},"references-count":2,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["0924977X94901074"],"URL":"https:\/\/doi.org\/10.1016\/0924-977x(94)90107-4","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[1994,9]]}},{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T07:15:38Z","timestamp":1698131738215},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1993,9,1]],"date-time":"1993-09-01T00:00:00Z","timestamp":746841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[1993,9]]},"DOI":"10.1016\/0924-977x(93)90057-s","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T04:05:30Z","timestamp":1039838730000},"page":"253-256","source":"Crossref","is-referenced-by-count":3,"title":["CCK provocation as a research tool in panic disorder"],"prefix":"10.1016","volume":"3","author":[{"given":"M.","family":"Bourin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bradwejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Palmour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0924-977X(93)90057-S_BIB1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/312363a0","article-title":"Benzodiazepine antagonize cholecystokinin-induceed activation of rat hippocampal neurons","volume":"312","author":"Bradwejn","year":"1984","journal-title":"Nature"},{"key":"10.1016\/0924-977X(93)90057-S_BIB2","first-page":"237","article-title":"Comparison of CO2 induced panic attacks with cholecystokinin-induced panic attacks in panic disorder","volume":"15","author":"Bradwejn","year":"1991","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/0924-977X(93)90057-S_BIB3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/070674379003500115","article-title":"Cholecystokinin-tetrapeptide induced panic attacks in patients with panic disorder","volume":"35","author":"Bradwejn","year":"1990","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/0924-977X(93)90057-S_BIB4","first-page":"260","article-title":"Dose ranging study of the effect of CCK-4 in healthy volunteers","volume":"16","author":"Bradwejn","year":"1991","journal-title":"J. Psychiatr. Neurosci."},{"key":"10.1016\/0924-977X(93)90057-S_BIB5","series-title":"New Concepts in Anxiety","first-page":"313","article-title":"Cholecystokinin-tetrapeptide: A provocation agent for research in panic disorders?","author":"Bradwejn","year":"1991"},{"key":"10.1016\/0924-977X(93)90057-S_BIB6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin-tetrapeptide in panic disorder: Clinical and behavioural findings","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/0924-977X(93)90057-S_BIB7","series-title":"New Research Program and Abstracts, 145th Meeting of the American Psychiatric Association","first-page":"164","article-title":"L-365,260: a CCKB antagonist blocks CCK-4 panic.","author":"Bradwejn","year":"1992"},{"key":"10.1016\/0924-977X(93)90057-S_BIB8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1176\/ajp.149.7.962","article-title":"Replication of action of cholecystokinin tetrapeptide in panic disorder: Clinical and behavioral findings","volume":"149","author":"Bradwejn","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/0924-977X(93)90057-S_BIB9","series-title":"Psychopharmacology of Panic","first-page":"110","article-title":"CCK-4 and panic disorders","author":"Bradwejn","year":"1993"},{"key":"10.1016\/0924-977X(93)90057-S_BIB10","article-title":"Flumazenil does not antagonise CCK-4 induced panic in healthy volunteers","author":"Bradwejn","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/0924-977X(93)90057-S_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1985.tb29900.x","article-title":"Comparative distribution of cholecystokinin and other neuropeptides","volume":"448","author":"Crawley","year":"1985","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/0924-977X(93)90057-S_BIB12","series-title":"144th Meeting of the American Psychiatric Association","first-page":"100","article-title":"A new primate model for panic disorder. New research program and abstracts","author":"Ervin","year":"1991"},{"key":"10.1016\/0924-977X(93)90057-S_BIB13","series-title":"Psychopharmacology: A Third Generation of Progress","first-page":"980","article-title":"Pharmacologic provocation of panic attacks","author":"Gorman","year":"1987"},{"key":"10.1016\/0924-977X(93)90057-S_BIB14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0010-440X(83)90059-7","article-title":"Pharmacologie models of anxiety","volume":"24","author":"Guttmacher","year":"1983","journal-title":"Comp. Psychiatry"},{"key":"10.1016\/0924-977X(93)90057-S_BIB15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00006842-198601000-00002","article-title":"Sodium lactate infusions and panic attacks: A review and critique","volume":"48","author":"Margraf","year":"1986","journal-title":"Psychosom. Med."},{"key":"10.1016\/0924-977X(93)90057-S_BIB16","first-page":"1130","article-title":"Evidence for an involvement of the brain cholecystokinin B receptor in anxiety","volume":"88","author":"Singh","year":"1991"},{"key":"10.1016\/0924-977X(93)90057-S_BIB17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02246976","article-title":"Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze","volume":"110","author":"Vasar","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/0924-977X(93)90057-S_BIB18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pa.31.040191.002345","article-title":"Cholecystokinin antagonists","volume":"31","author":"Woodruff","year":"1991","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0924977X9390057S?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0924977X9390057S?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T11:24:39Z","timestamp":1554117879000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0924977X9390057S"}},"issued":{"date-parts":[[1993,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["0924977X9390057S"],"URL":"https:\/\/doi.org\/10.1016\/0924-977x(93)90057-s","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[1993,9]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:39:45Z","timestamp":1720312785006},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/s0924-977x(05)00059-3","type":"journal-article","created":{"date-parts":[[2005,5,20]],"date-time":"2005-05-20T13:21:17Z","timestamp":1116595277000},"page":"S87","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["L.2 Current status of genetics of bipolar disorder"],"prefix":"10.1016","volume":"15","author":[{"given":"N.","family":"Craddock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T10:51:12Z","timestamp":1548499872000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05000593"}},"issued":{"date-parts":[[2005,1]]},"references-count":0,"alternative-id":["S0924977X05000593"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(05)00059-3","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2005,1]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:40:00Z","timestamp":1720312800655},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/s0924-977x(06)70338-8","type":"journal-article","created":{"date-parts":[[2006,11,9]],"date-time":"2006-11-09T12:23:10Z","timestamp":1163074990000},"page":"S314-S315","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S4","title":["P.2.c.004 Changes in sexual functions under mirtazapine treatment - primary data of a national, multicentre, prospective observational study in depressed patients"],"prefix":"10.1016","volume":"16","author":[{"given":"P.","family":"Osvath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Voros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Almasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X06703388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X06703388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T15:58:40Z","timestamp":1547222320000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X06703388"}},"issued":{"date-parts":[[2006,1]]},"references-count":0,"alternative-id":["S0924977X06703388"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(06)70338-8","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2006,1]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:22:30Z","timestamp":1720311750321},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1016\/s0924-977x(02)80391-1","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T12:42:19Z","timestamp":1041079339000},"page":"282","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S3","title":["Long-acting, injectable risperidone \u2014 the first long-acting, atypical antipsychotic \u2014 improves quality of life"],"prefix":"10.1016","volume":"12","author":[{"given":"N.","family":"Nasrallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mehnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Janagap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X02803911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X02803911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T19:28:13Z","timestamp":1553974093000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X02803911"}},"issued":{"date-parts":[[2002,10]]},"references-count":0,"alternative-id":["S0924977X02803911"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(02)80391-1","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2002,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:41:31Z","timestamp":1720312891525},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s0924-977x(14)70711-4","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T19:52:43Z","timestamp":1411674763000},"page":"S445","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["P.2.d.053 Causes of poor medication adherence in bipolar disorder: patients' perceptions and clinical realities"],"prefix":"10.1016","volume":"24","author":[{"given":"S.","family":"Bouhlel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sehli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kassaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nakhli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ben Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ben Hadj Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14707114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14707114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T07:53:14Z","timestamp":1538207594000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14707114"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"alternative-id":["S0924977X14707114"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(14)70711-4","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:41:37Z","timestamp":1720312897932},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s0924-977x(14)70682-0","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T23:52:52Z","timestamp":1411689172000},"page":"S427","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["P.2.d.024 Lithium and GSK-3\u03b2 promoter gene variants influence gray matter volume in bipolar disorder"],"prefix":"10.1016","volume":"24","author":[{"given":"S.","family":"Poletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14706820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14706820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T11:53:10Z","timestamp":1538221990000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14706820"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"alternative-id":["S0924977X14706820"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(14)70682-0","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:37:40Z","timestamp":1720312660098},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/s0924-977x(04)90083-1","type":"journal-article","created":{"date-parts":[[2004,4,28]],"date-time":"2004-04-28T16:45:35Z","timestamp":1083170735000},"page":"S66-S67","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["S.4.05 Reduced N-acetyl aspartate levels in the temporal cortex of rats reared in isolation"],"prefix":"10.1016","volume":"14","author":[{"given":"M.","family":"Harte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04900831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04900831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,9]],"date-time":"2019-02-09T21:25:02Z","timestamp":1549747502000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X04900831"}},"issued":{"date-parts":[[2004,1]]},"references-count":0,"alternative-id":["S0924977X04900831"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(04)90083-1","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2004,1]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:39:13Z","timestamp":1720312753433},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/s0924-977x(07)70927-6","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:40:20Z","timestamp":1196469620000},"page":"S593-S594","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S4","title":["P.8.a.024 Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case series"],"prefix":"10.1016","volume":"17","author":[{"given":"A.","family":"Str\u00f6hle*","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Harnack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Scheel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07709276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X07709276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T10:56:42Z","timestamp":1546426602000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X07709276"}},"issued":{"date-parts":[[2007,10]]},"references-count":0,"alternative-id":["S0924977X07709276"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(07)70927-6","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2007,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:22:23Z","timestamp":1720311743823},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1016\/s0924-977x(98)80366-0","type":"journal-article","created":{"date-parts":[[2003,8,12]],"date-time":"2003-08-12T12:43:24Z","timestamp":1060692204000},"page":"S222","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["Serotonin and dopamine receptor responsivity in schizophrenic patients in drug-free state or on haloperidol, and after treatment with clozapine"],"prefix":"10.1016","volume":"8","author":[{"given":"L.","family":"Lykouras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hatzimanolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Markianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X98803660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X98803660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T15:56:37Z","timestamp":1552578997000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X98803660"}},"issued":{"date-parts":[[1998,11]]},"references-count":0,"alternative-id":["S0924977X98803660"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(98)80366-0","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[1998,11]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:22:23Z","timestamp":1720311743980},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/s0924-977x(04)80485-1","type":"journal-article","created":{"date-parts":[[2005,1,5]],"date-time":"2005-01-05T07:29:50Z","timestamp":1104910190000},"page":"S348-S349","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S3","title":["P.5.022 Nicotine-induced antinociception, rewardingeffects and physical dependence are mediated by pre-proenkephalin derivates"],"prefix":"10.1016","volume":"14","author":[{"given":"F.","family":"Berrendero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mendiz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Galeote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bilkei-Gorzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04804851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04804851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T06:57:56Z","timestamp":1548831476000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X04804851"}},"issued":{"date-parts":[[2004,10]]},"references-count":0,"alternative-id":["S0924977X04804851"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(04)80485-1","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2004,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:22:27Z","timestamp":1720311747338},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/s0924-977x(04)80383-3","type":"journal-article","created":{"date-parts":[[2005,1,5]],"date-time":"2005-01-05T07:29:50Z","timestamp":1104910190000},"page":"S304","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S3","title":["P.3.003 A randomized, double-blind, 8-week comparison of venlafaxine XR and placebo in out-patients with Generalized Anxiety Disorder (GAD)"],"prefix":"10.1016","volume":"14","author":[{"given":"J.","family":"Kogeorgos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Nimatoudis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Zissis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tsilikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Charambopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zittis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Moulatsiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vidalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kaprinis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04803833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X04803833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:20:04Z","timestamp":1548832804000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X04803833"}},"issued":{"date-parts":[[2004,10]]},"references-count":0,"alternative-id":["S0924977X04803833"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(04)80383-3","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2004,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:48:27Z","timestamp":1720313307654},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s0924-977x(14)71148-4","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T23:47:29Z","timestamp":1411688849000},"page":"S712-S713","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["P.7.b.012 Testosterone and explosive aggression in children with autism spectrum disorders"],"prefix":"10.1016","volume":"24","author":[{"given":"A.","family":"Pivovarciova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hnilicova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tomova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ostatnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.C.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14711484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14711484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T11:55:01Z","timestamp":1538222101000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14711484"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"alternative-id":["S0924977X14711484"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(14)71148-4","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:50:39Z","timestamp":1720313439614},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s0924-977x(14)70183-x","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T19:49:44Z","timestamp":1411674584000},"page":"S134","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["S.18.02 Anti-inflammatory strategies in the treatment of schizophrenia"],"prefix":"10.1016","volume":"24","author":[{"given":"I.","family":"Sommer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.D.","family":"De Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Van Westrhenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1470183X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1470183X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T07:54:16Z","timestamp":1538207656000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1470183X"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"alternative-id":["S0924977X1470183X"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(14)70183-x","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T21:01:20Z","timestamp":1698181280217},"reference-count":1,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1991,9,1]],"date-time":"1991-09-01T00:00:00Z","timestamp":683683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[1991,9]]},"DOI":"10.1016\/0924-977x(91)90655-e","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T08:20:42Z","timestamp":1089879642000},"page":"444-445","source":"Crossref","is-referenced-by-count":1,"title":["Sertraline in the treatment of major depression: an open clinical stratification study in Italian outpatients"],"prefix":"10.1016","volume":"1","author":[{"given":"G","family":"Bersani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Ciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"De Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Rapisarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12(suppl B)","key":"10.1016\/0924-977X(91)90655-E_BIB1","first-page":"4","article-title":"Antidepressant efficacy of sertraline; a double-blind, placebo- and amitriptyline-controlled multicenter comparison study in outpatients with major depression","volume":"51","author":"Reimherr","year":"1990","journal-title":"J. Clin. Psych."}],"container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0924977X9190655E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0924977X9190655E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T15:57:30Z","timestamp":1549382250000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0924977X9190655E"}},"issued":{"date-parts":[[1991,9]]},"references-count":1,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1991,9]]}},"alternative-id":["0924977X9190655E"],"URL":"https:\/\/doi.org\/10.1016\/0924-977x(91)90655-e","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[1991,9]]}},{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:36:51Z","timestamp":1720312611757},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/s0924-977x(05)80226-3","type":"journal-article","created":{"date-parts":[[2005,5,20]],"date-time":"2005-05-20T09:21:17Z","timestamp":1116580877000},"page":"S101","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["S.4.3 Aging and brain degeneration"],"prefix":"10.1016","volume":"15","author":[{"given":"L.-G.","family":"Nilsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["European Neuropsychopharmacology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05802263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X05802263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T05:53:23Z","timestamp":1548482003000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X05802263"}},"issued":{"date-parts":[[2005,1]]},"references-count":0,"alternative-id":["S0924977X05802263"],"URL":"https:\/\/doi.org\/10.1016\/s0924-977x(05)80226-3","ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"published":{"date-parts":[[2005,1]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}